Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,776 | 66 | 42.9% |
| Unspecified | $62,282 | 55 | 22.3% |
| Consulting Fee | $47,939 | 18 | 17.2% |
| Food and Beverage | $30,463 | 928 | 10.9% |
| Travel and Lodging | $15,681 | 66 | 5.6% |
| Honoraria | $2,500 | 1 | 0.9% |
| Education | $247.26 | 16 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $60,361 | 238 | $0 (2024) |
| GlaxoSmithKline, LLC. | $44,144 | 184 | $0 (2024) |
| Glenmark Pharmaceuticals Inc. | $38,926 | 19 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $25,574 | 59 | $0 (2024) |
| GENZYME CORPORATION | $21,854 | 67 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $18,824 | 47 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $17,369 | 17 | $0 (2020) |
| Optinose US, Inc. | $16,458 | 52 | $0 (2024) |
| ALK-Abello, Inc | $8,395 | 65 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,407 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,255 | 94 | AstraZeneca Pharmaceuticals LP ($17,604) |
| 2023 | $15,929 | 106 | AstraZeneca Pharmaceuticals LP ($7,667) |
| 2022 | $9,572 | 106 | Chiesi USA, Inc. ($2,029) |
| 2021 | $8,056 | 91 | GlaxoSmithKline, LLC. ($2,503) |
| 2020 | $29,257 | 110 | GENZYME CORPORATION ($9,358) |
| 2019 | $55,431 | 219 | GlaxoSmithKline, LLC. ($14,512) |
| 2018 | $69,656 | 214 | Glenmark Pharmaceuticals Inc. ($21,541) |
| 2017 | $68,734 | 210 | Glenmark Pharmaceuticals Inc. ($17,385) |
All Payment Transactions
1,150 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Immunology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/27/2024 | Genentech, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $112.43 | General |
| Category: Immunology | ||||||
| 10/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $108.93 | General |
| Category: Immunology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $78.89 | General |
| 10/25/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $40.99 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/25/2024 | Teva Pharmaceuticals USA, Inc. | Albuterol Sulfate (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | CSL Behring | Kcentra (Biological), Haegarda | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $120.27 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: VACCINES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $17,385 | 11 |
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | Circassia Pharmaceuticals Inc | $10,119 | 5 |
| An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment | Circassia Pharmaceuticals Inc | $6,865 | 5 |
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $2,500 | 1 |
| CLI-05993AB8-02 | Chiesi USA, Inc. | $2,029 | 3 |
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, in Patients With Moderate-to-severe Chronic O | SANOFI US SERVICES INC. | $1,319 | 16 |
| AN OPEN LABEL, RANDOMISED, PARALLEL GROUP CLINICAL STUDY TO EVALUATE T | GlaxoSmithKline, LLC. | $523.17 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 300 | 1,540 | $95,290 | $26,461 |
| 2022 | 8 | 256 | 1,332 | $84,945 | $21,363 |
| 2021 | 9 | 264 | 1,308 | $80,170 | $21,271 |
| 2020 | 7 | 271 | 1,485 | $88,750 | $20,326 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 36 | 766 | $30,640 | $7,867 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 80 | $19,485 | $6,418 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 74 | $12,270 | $4,775 | 38.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 43 | 518 | $20,720 | $3,829 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $5,010 | $1,438 | 28.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,320 | $791.23 | 59.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 25 | 28 | $3,220 | $562.24 | 17.5% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 25 | 29 | $1,885 | $404.84 | 21.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $740.00 | $376.09 | 50.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 33 | 766 | $30,640 | $8,466 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 92 | $14,260 | $4,013 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 53 | $12,190 | $3,180 | 26.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 33 | 338 | $13,520 | $2,564 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,250 | $1,515 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,830 | $1,017 | 21.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 19 | 24 | $2,760 | $365.62 | 13.2% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 18 | 23 | $1,495 | $243.01 | 16.3% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 30 | 722 | $28,880 | $8,052 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 125 | $19,375 | $5,690 | 29.4% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 31 | 332 | $13,280 | $2,411 | 18.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 22 | $5,060 | $1,649 | 32.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 28 | 28 | $6,440 | $1,551 | 24.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $1,440 | $783.12 | 54.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 18 | 28 | $3,220 | $563.25 | 17.5% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 19 | 27 | $1,755 | $377.03 | 21.5% |
About Dr. Gary Steven, M.D
Dr. Gary Steven, M.D is a Specialist healthcare provider based in Greenfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972530699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Steven, M.D has received a total of $278,889 in payments from pharmaceutical and medical device companies, with $22,255 received in 2024. These payments were reported across 1,150 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,776).
As a Medicare-enrolled provider, Steven has provided services to 1,091 Medicare beneficiaries, totaling 5,665 services with total Medicare billing of $89,421. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Allergy
- Location Greenfield, WI
- Active Since 06/27/2006
- Last Updated 07/09/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1972530699
Products in Payments
- NUCALA (Biological) $27,758
- DUPIXENT (Biological) $22,279
- AIRSUPRA (Drug) $20,920
- Xhance (Drug) $16,437
- FASENRA (Drug) $13,748
- DUPIXENT DUPILUMAB INJECTION (Biological) $13,542
- DUPIXENT (Drug) $11,425
- XOLAIR (Biological) $10,693
- TRELEGY ELLIPTA (Drug) $7,988
- Odactra (Drug) $7,327
- BEVESPI AEROSPHERE (Drug) $6,907
- SPIRIVA RESPIMAT (Drug) $3,332
- Xembify (Biological) $2,863
- BREZTRI (Drug) $2,748
- FASENRA (Biological) $2,504
- ADVAIR (Drug) $2,500
- Oralair (Drug) $2,127
- Xolair (Biological) $1,982
- SAR440340 (Drug) $1,319
- BREZTRI AEROSPHERE (Drug) $967.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Greenfield
Mr. John Frangie, Md, MD
Specialist — Payments: $1,723
Mrs. Kimberly Heim, Np, NP
Specialist — Payments: $1,105
Dr. Thomas Echeverria, Md, MD
Specialist — Payments: $19.04
Sara Riddington, Msw, Lcsw, MSW, LCSW
Specialist
Justine Faraone, Pta, PTA
Specialist
Ms. Jean Conway, Cht, CHT
Specialist